The Syndromic Standard: Explore the Clinical Impact of mPCR GI Panels for Gastroenteritis

Tuesday, July 28
2:45 p.m. – 3:45 p.m.
Exhibit Hall Theater 1
Presented by bioMérieux

Overview

Join us for an insightful discussion on the evolving landscape of GI Molecular Diagnostics. Learn how the BioMérieux BIOFIRE GI Molecular portfolio is revolutionizing diagnostics, enabling accurate identification of bacterial, viral, and parasitic pathogens with the introduction of the BIOIFRE GI Panel Mid. Attendees will also gain valuable insight on the burden of gastroenteritis compiled by traditional stool testing, the clinical utility of the BioMérieux GI testing portfolio, in addition to testing implementation, utilization, and result interpretation. Discover how this solution supports clinicians in reducing diagnostic uncertainty, improving time-to-treatment, and advancing patient outcomes. Whether you’re a clinician or healthcare leader, this session will equip you with high-level knowledge to enhance GI diagnostic testing.

Moderator

Geremi Boom, PharmD, MBA, BCPS
Field Medical Director, bioMérieux

Speaker

Jordan Axelrad, MD, MPH
Co-Director, Inflammatory Bowel Disease Center, NYU Langone Health
Associate Professor of Medicine, Division of Gastroenterology
NYU Grossman School of Medicine